Loading clinical trials...
Loading clinical trials...
EEG-MRI Study of the Effect of Methylphenidate on Neural Mechanisms in Adult Patients With ADHD With or Without Mood Disorders: a Randomized Controlled Trial Versus Placebo
Conditions
Interventions
Placebo
Methylphenidate immediate release 25mg
Locations
1
France
Service de Psychiatrie 2, Hôpitaux Universitaires de Strasbourg
Strasbourg, France
Start Date
February 26, 2024
Primary Completion Date
May 1, 2027
Completion Date
May 1, 2027
Last Updated
July 31, 2024
Lead Sponsor
University Hospital, Strasbourg, France
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions